Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong Kong
Runhong Zhou(National Institute for Communicable Disease Control and Prevention), Zhiwei Chen(Fujian Medical University), Kelvin Kai‐Wang To(Hong Kong Science and Technology Parks Corporation), Ivan Fan‐Ngai Hung(Chinese University of Hong Kong), Ka‐Kit Au(University of Hong Kong), Jian‐Piao Cai(University of Hong Kong), Dawei Yang(University of Hong Kong), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Haode Huang(Chinese University of Hong Kong), Zhenglong Du(Beibu Gulf University), Xin Li(University of Hong Kong), Na Liu(Qingdao University), Xiao‐Ning Xu(John Radcliffe Hospital), Hau-Yee Kwok(University of Hong Kong), Qiaoli Peng(Shenzhen Third People’s Hospital), Cheuk-Kwan Yiu(Chinese University of Hong Kong)
Cited by 27
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k
Coronaviruses — drug discovery and therapeutic options
|Nature Reviews Drug Discovery|2016|1.8k